If you have been reading about BPC-157 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-10-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
=== Physical properties === Calcium metal melts at 842 °C and boils at 1494 °C; these values are higher than those for magnesium and strontium, the neighbouring group 2 metals. It crystallises in the face-centered cubic arrangement like strontium and barium; above 443 °C (716 K), it changes to body-centered cubic. Its density of 1.526 g/cm3 (at 20 °C) is the lowest in its group. Calcium is harder than lead but can be cut with a knife with effort. While calcium is a poorer conductor of electricity than copper or aluminium by volume, it is a better conductor by mass than both due to its very low density. While calcium is infeasible as a conductor for most terrestrial applications as it reacts quickly with atmospheric oxygen, its use as such in space has been considered.
== Signaling == Activation of the adenosine A1 receptor by an agonist causes binding of Gi1/2/3 or Go protein. Binding of Gi1/2/3 causes an inhibition of adenylate cyclase and, therefore, a decrease in the cAMP concentration. An increase of the inositol triphosphate/diacylglycerol concentration is caused by an activation of phospholipase C, whereas the elevated levels of arachidonic acid are mediated by DAG lipase, which cleaves DAG to form arachidonic acid. Several types of potassium channels are activated but N-, P-, and Q-type calcium channels are inhibited.
Two days later, five Italian fighters attacked a group of grounded Rhodesian aircraft at Agordat in western Eritrea, and wrecked two Hardys and two Lysanders. Platt's advance into Eritrea was checked during the seven-week Battle of Keren (February–April 1941), during which No. 237 Squadron observed Italian positions and took part in bombing raids. After the Italians retreated and surrendered, the Rhodesian squadron moved forward to Asmara on 6 April, whence it embarked on bombing sorties on the port of Massawa. The same day, the Italian garrison in the Abyssinian capital Addis Ababa surrendered to the 11th (East Africa) Division, including many Rhodesians. During the Battle of Amba Alagi, Platt and Cunningham's forces converged and surrounded the remainder of the Italians, who were commanded by the Duke of Aosta at the mountainous stronghold of Amba Alagi. The viceroy surrendered on 18 May 1941, effectively ending the war in East Africa. No. 237 Squadron and the Rhodesian Anti-Tank Battery thereupon moved up to Egypt to join the war in the Western Desert. Some Italian garrisons continued to fight—the last surrendered only following the Battle of Gondar in November 1941. Until this time the partly Rhodesian-commanded Nigeria and Gold Coast Regiments remained in Abyssinia, patrolling and rounding up scattered Italian units. Around 250 officers and 1,000 other ranks from Southern Rhodesia remained in Kenya until mid-1943.
Sources: en.wikipedia.org
=== Journalists === William Henry Leggett (1837), botanist and journalist who founded the Torrey Botanical Bulletin Henry Demarest Lloyd (1867), muckraking journalist, "father of investigative journalism" Herbert Agar (1919), journalist and historian, winner of the Pulitzer Prize for History in 1934 Matthew Josephson (1920), journalist credited with popularizing the term "Robber baron" Herbert Matthews (1922), foreign correspondent for The New York Times who first reported Fidel Castro alive in the Sierra Maestra David Cort (1924), foreign news editor at Life magazine William Brown Meloney V (1926), journalist, son of noted journalist Marie Mattingly Meloney Ernest Cuneo (1927), president, North American Newspaper Alliance Harold Isaacs (1930), journalist and MIT professor who wrote extensively on the Chinese Civil War Peter C. Rhodes (1933), journalist who worked for United Press International and the United States Office of War Information Harry Schwartz (1940), editorial writer for The New York Times Phelan Beale Jr. (1944), journalist; first cousin of Jacqueline Kennedy Onassis Charles E. Silberman (1945), author and journalist Kennett Love (1948), journalist for The New York Times David Wise (1951), author of espionage and national security nonfiction Daniel S. Greenberg (1953), science journalist, brother of Jack Greenberg '45 Barry Schweid (1953), Associated Press correspondent Walter Karp (1955), journalist, historian, contributing editor to Harper's Magazine Warren Boroson (1957), journalist; editor of Fact Magazine William E.
Joshua Coon is a professor of chemistry and biomolecular chemistry and the inaugural holder of the Thomas and Margaret Pyle Chair at the University of Wisconsin–Madison, and an affiliate of the Morgridge Institute for Research. Coon develops scientific instruments to measure molecules in living systems. He focuses specifically on the use of mass spectrometry to measure the molecular mass of biomolecules, and its application to proteomics. Joshua Coon, along with John Syka, developed electron-transfer dissociation (ETD) while working as a postdoctoral student in Donald Hunt's lab at the University of Virginia.
Widespread use Spironolactone — the first and most widely used member of this class Eplerenone — much more selective than spironolactone on target, but somewhat less potent and efficacious Uncommon use (to date) Canrenone and potassium canrenoate — very limited use Finerenone — nonsteroidal and more potent and selective than either eplerenone or spironolactone Some drugs also have antimineralocorticoid effects secondary to their main mechanism of actions. Examples include progesterone, drospirenone, gestodene, metribolone, and benidipine.
Sources: en.wikipedia.org
Larry Overman and coworkers make use of the Stille-carbonylative cross-coupling in their 20-step enantioselective total synthesis of strychnine. The added carbonyl is later converted to a terminal alkene via a Wittig reaction, allowing for the key tertiary nitrogen and the pentacyclic core to be formed via an aza-Cope-Mannich reaction.
5-HTP has been used medically and as a supplement under the name oxitriptan in the treatment of depression and for certain other indications. As of 2025, there are no current FDA approved medications containing 5-HTP. It can be potentiated in combination with a peripherally selective aromatic L-amino acid decarboxylase (AAAD) inhibitor such as carbidopa or benserazide. These agents increase the strength and duration of oxitriptan. An investigational combination formulation is oxitriptan/carbidopa.
Counter-Strike: Source has been played in tournaments since shortly after its release. However, the game received criticism from parts of the competitive community, who felt that it was not sufficiently refined for high-level competitive play and that its skill ceiling was significantly lower than that of Counter-Strike 1.6. One common criticism concerned the altered recoil patterns of automatic weapons, which were more random than in the original game and were viewed by many players as reducing the importance of mechanical skill. Another major point of contention was the reduction in bullet penetration through walls, while grenade explosions could no longer inflict damage through solid surfaces. Changes to grenade mechanics were also criticized by some players for altering established strategies from previous versions of the game. Players additionally pointed to shortcomings in the game's lag compensation system, which could cause discrepancies between player models and their hitboxes. The game's significantly higher hardware requirements compared to Counter-Strike 1.6 also proved to be a barrier for some competitive players and organizations, particularly during the early years following its release. This caused a divide in the competitive community as to which game to play competitively.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
The dry powder is the stable form and the dissolved form is comparatively fragile. Freezing a solution slows degradation but does not stop it, and repeated freezing and thawing adds further stress. Many laboratories therefore prepare small single-use portions rather than storing one large volume.